| Literature DB >> 33100746 |
Vikram P Satav1, Sonu Sharma1, Rohit Kapoor1, Vilas P Sabale1, Avreen Singh Shah1, Ashwani Kandari1.
Abstract
CONTEXT: Management of urolithiasis in patients with chronic kidney disease. AIMS: To ascertain the best method surgical or noninvasive. SETTINGS ANDEntities:
Keywords: Chronic kidney disease; percutaneous nephrolithotomy; renal functions; ureteroscopic lithotripsy; urolithiasis
Year: 2020 PMID: 33100746 PMCID: PMC7546062 DOI: 10.4103/UA.UA_122_19
Source DB: PubMed Journal: Urol Ann ISSN: 0974-7796
Demographic, clinical, and biochemical profile of chronic kidney disease patients with urolithiasis and proposed management strategies
| Characteristic | Statistic |
|---|---|
| Mean age (years)±SD (range) | 55.22±10.17 (28-75) |
| Gender, | |
| Male | 38 (76.0) |
| Female | 12 (24.0) |
| Mean Hb±SD (gm%) | 9.49±0.84 |
| Mean serum urea±SD (mg/dl) | 71.13±24.09 |
| Mean serum creatinine±SD (mg/dl) | 4.71±2.45 |
| Mean TLC±SD (thousands/cumm) | 8.67±1.81 |
| Laterality, | |
| U/L | 37 (74.0) |
| B/L | 13 (26.0) |
| Management strategy | |
| PCNL (U/L, BL) | 23 (18, 5) |
| URSL (U/L, BL) | 12 (5, 7) |
| ESWL | 4 |
| PCNL with URSL | 5 |
| Laparoscopic ureterolithotomy | 2 |
| URSL with cystolithotripsy | 1 |
| Cystolithotripsy (B/L) | 1 |
| PCNL with laparoscopic ureterolithotomy | 1 |
| Cystolithotomy with ureterolithotomy open | 1 |
SD: Standard deviation, Hb: Hemoglobin, TLC: Total leukocyte count, URSL: Ureteroscopic lithotripsy, ESWL: Extracorporeal shock wave lithotripsy, PCNL: Percutaneous nephrolithotomy, U/L: Unilateral, B/L: Bilateral
Association between management strategy and complete clearance of stones
| Management strategy | Total number of cases | Number of cases with complete clearance | Rate of complete clearance (%) |
|---|---|---|---|
| PCNL | 23 | 18 | 78.3 |
| URSL | 12 | 11 | 91.7 |
| PCNL with URSL | 5 | 2 | 40.0 |
| ESWL | 4 | 3 | 75.0 |
| Others | 6 | 5 | 83.3 |
| Total | 50 | 39 | 78.0 |
χ2=5.63, df=4, P=0.228. PCNL: Percutaneous nephrolithotomy, URSL: Ureteroscopic lithotripsy, ESWL: Extracorporeal shock wave lithotripsy
Postoperative complications, biochemical, follow-up profile, and outcome (n=50)
| Characteristic | Statistic |
|---|---|
| Postoperative complications, | |
| Fever | 20 (40.0) |
| Hemodialysis | 8 (16.0) |
| Bleeding | 6 (12.0) |
| Sepsis | 3 (6.0) |
| Mean postoperative Hb±SD (gm%) | 8.75±0.85* |
| Mean postoperative TLC±SD (thousands/cumm) | 9.74±2.64 |
| Renal functions (mg/dl) | |
| Immediate postoperative, mean serum urea±SD | 56.76±21.46* |
| Immediate postoperative, mean serum creatinine±SD | 3.78±1.51* |
| Mean serum creatinine±SD at 3 months FU ( | 3.16±1.11* |
| Mean serum creatinine±SD at 6 months FU ( | 2.85±0.82* |
| Outcome, | |
| Survived | 45 (90) |
| Death | 2 (4) |
| Loss to FU | 3 (6) |
| Auxiliary procedure need, | 6 (12) |
| Miniperc | 4 |
| ESWL | 1 |
| ESWL | 1 |
*Significant as compared to baseline values paired t-test. SD: Standard deviation, Hb: Hemoglobin, TLC: Total leukocyte count, FU: Follow-up, URSL: Ureteroscopic lithotripsy, ESWL: Extracorporeal shock wave lithotripsy